Business Description
Mesa Laboratories Inc
NAICS : 334513
SIC : 3823
ISIN : US59064R1095
Share Class Description:
MLAB: Ordinary SharesDescription
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, cleaning, and chemical indicators. It also provides testing and laboratory services, mainly to the dental industry; Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions; Calibration Solutions division develops, manufactures, and sells quality control and calibration products used to measure or calibrate temperature, pressure, pH, humidity, and other such parameters for health and safety purposes; and Clinical Genomics. Its geographical segments include United States and Foreign.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.12 | |||||
| Equity-to-Asset | 0.54 | |||||
| Debt-to-Equity | 0.59 | |||||
| Debt-to-EBITDA | 6.07 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 1.53 | |||||
| Beneish M-Score | -2.94 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 14.9 | |||||
| 3-Year EBITDA Growth Rate | 11.7 | |||||
| 3-Year EPS without NRI Growth Rate | -25.4 | |||||
| 3-Year FCF Growth Rate | -9.2 | |||||
| 3-Year Book Growth Rate | 13.5 | |||||
| Future 3-5Y Total Revenue Growth Rate | 5.05 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.28 | |||||
| 9-Day RSI | 41.54 | |||||
| 14-Day RSI | 45.07 | |||||
| 6-1 Month Momentum % | -5.43 | |||||
| 12-1 Month Momentum % | -40.43 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.68 | |||||
| Quick Ratio | 1.86 | |||||
| Cash Ratio | 0.64 | |||||
| Days Inventory | 152.01 | |||||
| Days Sales Outstanding | 66.15 | |||||
| Days Payable | 24.08 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.63 | |||||
| Dividend Payout Ratio | 3.76 | |||||
| Forward Dividend Yield % | 0.63 | |||||
| 5-Year Yield-on-Cost % | 0.65 | |||||
| 3-Year Average Share Buyback Ratio | -7 | |||||
| Shareholder Yield % | 2.91 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 61.02 | |||||
| Operating Margin % | -0.13 | |||||
| Net Margin % | 0.45 | |||||
| FCF Margin % | 19.12 | |||||
| ROE % | 0.24 | |||||
| ROA % | 0.14 | |||||
| ROIC % | 0.07 | |||||
| ROC (Joel Greenblatt) % | 6.1 | |||||
| ROCE % | 0.73 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 597.06 | |||||
| PE Ratio without NRI | 597.06 | |||||
| Shiller PE Ratio | 66.6 | |||||
| Price-to-Owner-Earnings | 16.82 | |||||
| PEG Ratio | 39.8 | |||||
| PS Ratio | 2.57 | |||||
| PB Ratio | 1.36 | |||||
| Price-to-Free-Cash-Flow | 13.42 | |||||
| Price-to-Operating-Cash-Flow | 12.49 | |||||
| EV-to-EBIT | 164.35 | |||||
| EV-to-EBITDA | 19.4 | |||||
| EV-to-Revenue | 3.55 | |||||
| EV-to-FCF | 18.55 | |||||
| Price-to-Projected-FCF | 0.81 | |||||
| Price-to-Median-PS-Value | 0.44 | |||||
| Price-to-Peter-Lynch-Fair-Value | 55.16 | |||||
| Earnings Yield (Greenblatt) % | 0.61 | |||||
| FCF Yield % | 7.44 | |||||
| Forward Rate of Return (Yacktman) % | 17.14 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:MLAB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Mesa Laboratories Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 212.874 | ||
| EPS (TTM) ($) | 0.17 | ||
| Beta | 1.17 | ||
| Volatility % | 52.38 | ||
| 14-Day RSI | 45.07 | ||
| 14-Day ATR ($) | 4.682958 | ||
| 20-Day SMA ($) | 104.0185 | ||
| 12-1 Month Momentum % | -40.43 | ||
| 52-Week Range ($) | 82.86 - 178.64 | ||
| Shares Outstanding (Mil) | 5.39 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Mesa Laboratories Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Mesa Laboratories Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Mesa Laboratories Inc Frequently Asked Questions
What is Mesa Laboratories Inc(MLAB)'s stock price today?
The current price of MLAB is $101.50. The 52 week high of MLAB is $178.64 and 52 week low is $82.86.
When is next earnings date of Mesa Laboratories Inc(MLAB)?
The next earnings date of Mesa Laboratories Inc(MLAB) is 2024-05-24 Est..
Does Mesa Laboratories Inc(MLAB) pay dividends? If so, how much?
The Dividend Yield %  of Mesa Laboratories Inc(MLAB) is 0.63% (As of Today), Highest Dividend Payout Ratio of Mesa Laboratories Inc(MLAB) was 3.77. The lowest was 0.15. And the median was 0.26. The  Forward Dividend Yield % of Mesa Laboratories Inc(MLAB) is 0.63%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers